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patients with RA. Dimensionality of the combined instrument was explored by fac-
tor analyses (exploratory and confirmatory). Two approaches were taken to address 
the multi-factor/dimensionality issue identified through factor analysis. The first 
approach was to fit a sequence of unidimensional Rasch and generalized partial credit 
(GPC) models to each factor. Model comparisons and diagnoses were performed to 
assess the adequacy of model fitting and to detect any violation of the underlying 
assumptions. The second approach was to fit a multi-dimensional IRT model to these 
items. Results: The factor analysis suggested there were three underlying factors 
in the combined PF10 and HAQ-DI. These three factors can be best characterized as 
hygiene (including 4 items from HAQ-DI and 1 from PF10), lower body activity (includ-
ing 8 items from HAQ-DI and 6 from PF10) and upper body activity (including 7 items 
from HAQ-DI and 3 from PF10). Overall, the GPC model significantly outperformed 
the Rasch model across all factors (all p-value< 0.0001), implying divergent discrimi-
nability among items within each factor. The multi-dimensional IRT improved the 
model fit but substantially increased the computation effort and sacrificed model 
interpretability. ConClusions: The pooled HAQ-DI and PF10 items represent mul-
tiple domains of physical functioning. To explain the combination of these items, a 
multi-dimensional IRT model decreased model interpretability and increased com-
putation intensity compared to unidimensional models.
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objeCtives: Fatigue is highly prevalent, disabling, and remains under-reported and 
undertreated in rheumatoid arthritis (RA). NIH generic PROMIS®measures can assess 
PROs across health domains relevant to chronic conditions. PROMIS offers item banks 
for computer adaptive testing (CAT), paper-based short forms (SF), and single items. 
The PROMIS fatigue item bank assesses both experience (from mild tiredness to an 
overwhelming, sustained sense of exhaustion) and impact on physical, mental and 
social activities. Little is known about the feasibility and validity of PROMIS fatigue 
measures in RA trials. Methods: Data are from the first 139 RA patients enrolled 
in an ongoing study integrating PROs into routine care at an arthritis center. Three 
PROMIS fatigue measures (CAT [5-8 items], 7-item SF, and Global Health single item) 
were administered in random order with other legacy measures. Spearman correla-
tions were used to evaluate convergent validity. Results: Participants were mostly 
female (81%) and white (85%), with a mean (SD) age of 56 (13), and RA duration of 12 
(9) yrs. Mean (SD) t-scores for the PROMIS CAT and SF were 54.1 (10.2) and 53.6 (8.9); 
the single item was 2.6/5 (.9). PROMIS measures correlated highly with a fatigue VAS 
(.78-.87), moderately with disease activity indicators including pain (.60-.68), patient 
global (.66-.72), physical function (.53-.69) and CDAI (.54-.65), and weakly with MD 
global (.36-.39). A dose-response relationship was evident across disease activity levels 
in all measures. ConClusions: Our study contributes evidence of the feasibility of 
using PROMIS fatigue instruments in RA visits and of construct validity. While the 
PROMIS Fatigue CAT was most strongly associated with legacy measures and offers 
greater precision, the SF and single item performed adequately and are useful when 
paper or briefer versions are needed. Evaluation of responsiveness and validity across 
diverse patient groups and settings is needed.
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objeCtives: The 4-item Morisky Medication Adherence Scale (MMAS-4) and more 
recent 8-item version (MMAS-8) have both been validated and demonstrate concur-
rent validity among patients with hypertension, but the extent to which the scales 
can be compared has received little attention. This study assessed the comparability 
of adherence scores obtained with these scales in patients with type 2 diabetes (T2D) 
as well as the feasibility of integrating results across the scales using 4 items of the 
MMAS-8. Methods: Data were taken from the 2011 and 2012 US National Health 
and Wellness Survey (NHWS). The NHWS is a large cross-sectional survey representa-
tive of the total adult population in several major markets; N~75,000/year in the 
US. A total of 13,007 respondents self-reported physician diagnosis of T2D and were 
administered MMAS-4 in 2011 or MMAS-8 in 2012. The two adherence scales were 
evaluated by comparing the frequency distributions of the MMAS scores for the two 
scales, Cronbach’s alpha and inter-item correlations, and the creation of a new 4-item 
scale including the questions in MMAS-8 that best matched the questions in MMAS-
4. Results: In T2D patients, both MMAS-4 and -8 scores are Poisson-like distributed, 
with median at zero (high adherence) for MMAS-4 and at 1 (medium adherence) for 
MMAS-8. Chronbach’s alpha was 0.55 for MMAS-4 and 0.71 for MMAS-8, while aver-
age item-test correlations were 0.65 and 0.57, respectively. The reduced 4-item scale 
created out of MMAS-8 is also Poisson-like distributed, Cronbach’s alpha was 0.62 and 
the average item-test correlation was 0.68. ConClusions: Scores of the two MMAS 
show similar qualitative and quantitative characteristics, suggesting that it may be 
appropriate to integrate data sources using the two different versions, particularly 
when the responses to the subset of 4 MMAS-8 items are available. Future research 
should confirm that the scales can be integrated in different therapeutic areas.
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objeCtives: The Diabetes Treatment Satisfaction Questionnaire (DTSQ), developed 
in UK English by Professor Clare Bradley, is a reliable, valid and widely used 8-item 
and response options as intended. The Fatigue Symptoms and Impacts Questionnaire-
RMS (FSIQ-RMS™) comprises 23 items organized in a conceptual framework with 2 
symptom domains (energy, muscle weakness) and 7 impact domains (daily activities, 
cognition, emotions, physical impact, self-care, sleep, social impact). As no novel 
concepts were reported by more than two patients per sub-group during content 
confirmation, the PRO was not revised. ConClusions: The FSIQ-RMS™ was dem-
onstrated to be a comprehensive measure of fatigue-related symptoms and impacts 
in RMS patients, supporting initial content validity. Before it can be used in clinical 
practice or studies, final psychometric validation will be evaluated in a multicenter, 
observational trial in RMS patients.
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objeCtives: Personal recovery is “a deeply personal, unique process of changing 
ones’ attitudes, values, feelings, goals, skills and/or roles…a way of living a satisfying, 
hopeful and contributing life even with the limitations caused by illness.”[Wayne, 
1993]. As more research studies attempt to assess personal recovery in the evalu-
ation of treatments for serious mental illness, an evaluation of personal recovery 
tools is necessary to assess utility, validity and applicability. Our goal was to identify 
individual measures of personal recovery that had been evaluated in schizophre-
nia. Methods: We undertook a systematic review of the literature utilizing 9 data 
sources (PubMed, Embase, CINAHL, and others). These databases were searched 
using a systematic search strategy. The results were sub-divided into 4 categories: 
Personal Recovery, Schizophrenia & Related Disorders, Measure or Instrument, and 
Psychometric Properties or Validation and abstracted. Results: Nearly 2,000 unique 
titles/abstracts of published literature were identified through the described search 
process. These were evaluated against pre-specified criteria and abstracted. After 
review of each article, < 300 articles met the full criteria for abstraction. In these arti-
cles, 23 unique measures were identified and 18 had been used in the assessment of 
personal recovery in schizophrenia patients. Psychometric properties of these instru-
ments were then assessed for internal consistency, test-retest reliability and sensitiv-
ity to change; most had not been validated. ConClusions: Measures of personal 
recovery can inform important aspects of clinical, humanistic, and economic trials 
in mental health. Validated scales for schizophrenia that are sensitive to change over 
the course of the illness and its treatment, should allow for a better understanding of 
patients’ functional disabilities, enabling more comprehensive monitoring and evalu-
ation of treatment strategies . While several recovery measures exist, most are too 
broad and are not validated for use in the schizophrenic population. Future research 
should focus on further development and validation of these measures.
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objeCtives: To explore the feasibility and utility of using social media-based 
patient networks to gather qualitative data on patient reported outcome (PRO) 
concepts relevant to Chronic Lymphocytic Leukemia (CLL). Methods: Adults with 
CLL participating as members of the PatientsLikeMe online patient community 
were invited to complete a web-based survey about their experiences with the 
condition. Open-ended survey questions elicited descriptions of CLL symptoms, 
impacts, and treatment-related perceptions. Other questions included CLL stage 
and treatment status, performance status, and demographic characteristics. Survey 
responses and interview transcripts were coded for qualitative content analysis 
using Atlas.ti. Results: Survey responses from 50 members of the PatientsLikeMe 
CLL community were coded for content analysis. The mean age of respondents 
was 60.5 years, 54.0% were female, and 96% were White. When surveyed, 20% of 
respondents were receiving current treatment. Among those not receiving treat-
ment, the majority (77.5%) were treatment naïve, while another 20% were in remis-
sion. The majority of patients (78.0%) reported experiencing at least 1 symptom and 
17% of patients reported their symptoms required them to be in bed for up to 50% 
of their waking day. Among 50 patients, 369 descriptions of CLL symptoms were 
coded. Fatigue was the most frequently-expressed symptom (described by 40% of 
respondents), followed by tiredness (38%), night sweats (38%), swollen lymph nodes 
(32%), and frequent infections (28%). Among impacts of CLL, worry and fear (66% of 
respondents), depressed feelings (52%), and work limitations (50%) were noted most 
frequently. ConClusions: Survey results identified constitutional symptoms of 
CLL included in existing PRO instruments and the literature. These findings suggest 
that qualitative data obtained through social media applications can be potentially 
useful in supporting concept identification for newly-developed PRO instruments. 
Further research is needed to identify whether the results can support content 
validity in the same way as established qualitative research methods.
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objeCtives: To explore the dimensionality of the PF construct when HAQ-DI and PF10 
items are combined into a single instrument. Methods: Item Response Theory (IRT) 
was used to analyze data from a phase 3, randomized, placebo-controlled study in 
